229 related articles for article (PubMed ID: 8097699)
1. Inhibitory effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in mouse lung explants.
Bouchard L; Castonguay A
Drug Metab Dispos; 1993; 21(2):293-8. PubMed ID: 8097699
[TBL] [Abstract][Full Text] [Related]
2. Effects of sulindac and oltipraz on the tumorigenicity of 4-(methylnitrosamino)1-(3-pyridyl)-1-butanone in A/J mouse lung.
Pepin P; Bouchard L; Nicole P; Castonguay A
Carcinogenesis; 1992 Mar; 13(3):341-8. PubMed ID: 1547522
[TBL] [Abstract][Full Text] [Related]
3. Effect of phenethyl isothiocyanate on the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured rat lung tissue.
Doerr-O'Rourke K; Trushin N; Hecht SS; Stoner GD
Carcinogenesis; 1991 Jun; 12(6):1029-34. PubMed ID: 2044181
[TBL] [Abstract][Full Text] [Related]
4. Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in lung tissue from mouse, rat, hamster, and man.
Richter E; Engl J; Friesenegger S; Tricker AR
Chem Res Toxicol; 2009 Jun; 22(6):1008-17. PubMed ID: 19408892
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured monkey lung explants.
Hecht SS; Trushin N; Chhabra SK; Anderson LM; Nerurkar PV
Drug Metab Dispos; 2000 Jan; 28(1):5-9. PubMed ID: 10611133
[TBL] [Abstract][Full Text] [Related]
6. Comparative metabolism of the tobacco-related carcinogens benzo[a]pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and N'- nitrosonornicotine in human hepatic microsomes.
Staretz ME; Murphy SE; Patten CJ; Nunes MG; Koehl W; Amin S; Koenig LA; Guengerich FP; Hecht SS
Drug Metab Dispos; 1997 Feb; 25(2):154-62. PubMed ID: 9029045
[TBL] [Abstract][Full Text] [Related]
7. Carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in cytosol of mouse liver and lung.
Atalla A; Maser E
Toxicology; 1999 Nov; 139(1-2):155-66. PubMed ID: 10614696
[TBL] [Abstract][Full Text] [Related]
8. Use of precision-cut tissue slices in organ culture to study metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by hamster lung, liver and kidney.
Richter E; Friesenegger S; Engl J; Tricker AR
Toxicology; 2000 Apr; 144(1-3):83-91. PubMed ID: 10781874
[TBL] [Abstract][Full Text] [Related]
9. Recovery from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced immunosuppression in A/J mice by treatment with nonsteroidal anti-inflammatory drugs.
Rioux N; Castonguay A
J Natl Cancer Inst; 1997 Jun; 89(12):874-80. PubMed ID: 9196254
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and DNA single strand breaks induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its analogues in primary culture of rat hepatocytes.
Liu LL; Alaoui-Jamali MA; el Alami N; Castonguay A
Cancer Res; 1990 Mar; 50(6):1810-6. PubMed ID: 2306734
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human kidney epithelial cells transfected with rat CYP2B1 cDNA.
Lacroix D; Desrochers M; Castonguay A; Anderson A
Carcinogenesis; 1993 Aug; 14(8):1639-42. PubMed ID: 8353848
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells.
Smith TJ; Guo Z; Gonzalez FJ; Guengerich FP; Stoner GD; Yang CS
Cancer Res; 1992 Apr; 52(7):1757-63. PubMed ID: 1312898
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by hamster respiratory tissues cultured with ellagic acid.
Castonguay A; Allaire L; Charest M; Rossignol G; Boutet M
Cancer Lett; 1989 Jul; 46(2):93-105. PubMed ID: 2752387
[TBL] [Abstract][Full Text] [Related]
14. Cell specificity for the pulmonary metabolism of tobacco-specific nitrosamines in the Fischer rat.
Belinsky SA; White CM; Trushin N; Hecht SS
Carcinogenesis; 1989 Dec; 10(12):2269-74. PubMed ID: 2591016
[TBL] [Abstract][Full Text] [Related]
15. Biotransformation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in freshly isolated human lung cells.
Smith GB; Castonguay A; Donnelly PJ; Reid KR; Petsikas D; Massey TE
Carcinogenesis; 1999 Sep; 20(9):1809-18. PubMed ID: 10469628
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes and its inhibition by isothiocyanates.
Smith TJ; Guo ZY; Thomas PE; Chung FL; Morse MA; Elkind K; Yang CS
Cancer Res; 1990 Nov; 50(21):6817-22. PubMed ID: 2208146
[TBL] [Abstract][Full Text] [Related]
17. Intestinal metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rats: Sex difference, inducibility and inhibition by phenethylisothiocyanate.
Schulze J; Malone A; Richter E
Carcinogenesis; 1995 Aug; 16(8):1733-40. PubMed ID: 7634397
[TBL] [Abstract][Full Text] [Related]
18. Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides.
Smith TJ; Stoner GD; Yang CS
Cancer Res; 1995 Dec; 55(23):5566-73. PubMed ID: 7585636
[TBL] [Abstract][Full Text] [Related]
19. Effects of nonsteroidal antiinflammatory drugs on oxidative pathways in A/J mice.
Bilodeau JF; Wang M; Chung FL; Castonguay A
Free Radic Biol Med; 1995 Jan; 18(1):47-54. PubMed ID: 7896170
[TBL] [Abstract][Full Text] [Related]
20. Effects of NSAIDs on NNK-induced pulmonary and gastric tumorigenesis in A/J mice.
Jalbert G; Castonguay A
Cancer Lett; 1992 Sep; 66(1):21-8. PubMed ID: 1451092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
